Sep 01,2016

Takeda Awarded $19.8 Million for Zika Vaccine

Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections. Work to develop the vaccine could earn Takeda, in Osaka, Japan, as much as $312 million if the Biomedical Advanced Research and Development Authority or BARDA, in the U.S. Department of Health and Human Services, exercises all options with the company including late-stage clinical trials and filing a biologics drug application at the Food and Drug Administration.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Dec 16,2016

Oncology-centric informatics firm Cota raises $18M

Cota, an oncology-centric data analytics company, has closed an $18 million growth equity round. Boston Millennia Partners was among the new investors in Cota, which builds technology to measure patient outcomes from specific treatment protocols. (The name stands for Cancer Outcomes Tracking and Analysis.) This is the second major investment in Cota this year. In May, pharma manufacturers Celgene and Novartis joined molecular information company Foundation Medicine and consulting firm HealthScape Advisors to make unspecified investments.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 27,2017

Insilico Medicine Raises $10 million in Equity Financing

Insilico Medicine, a company focused on artificial intelligence-driven drug discovery and aging research, has raised $10 million USD through a private offering of securities, according to the SEC form registered.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 01,2017

Medisafe raises $14.5M, announces European expansion

Medication adherence startup MediSafe has raised $14.5 million in a round led by Octopus Ventures and M Ventures (the venture arm of Merck Pharmaceuticals), with participation from existing investors Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. The company also announced that it will begin expanding into Europe using some of the funds.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 09,2017

LEO Innovation Lab invests $5.5 million in healthtech

LEO Innovation Lab, the innovation arm of LEO Pharma, this week announced a $5.5 million investment in five startups serving the healthtech sector. Specifically, the firm backs startups that help people achieve healthy skin: SkinVision (Holland) is a developer of an app that can analyze and track changes in moles and other skin conditions by using the smartphone's camera.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 15,2017

Goodlifeme Rasies $1.5m in Funding

Goodlifeme AB, a Swedish public limited company which has developed a gamified health-behavior change platform, rasied $1.5m in funding. The round was led by Frumtak Ventures with participation from existing shareholders.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
May 12,2017

Entia receives £1 million to develop take-home blood testing kit

They've only been around for two years but this healthtech start-up has already secured £1.14 million in funding to develop a hand-held blood testing kit for chemotherapy patients. The home blood cell count analyser promises to help cut wasted hospital visits for patients who aren't ready for chemotherapy treatment. Entia, based in Highbury, North London, were awarded the Early-Stage Biomedical Catalyst grant from government tech investment agency Innovate UK, allowing for the accelerated development of their home monitoring solution for cancer sufferers. The grant will allow them to work closely with one of the world's leading cancer care centres, The Royal Marsden Hospital NHS Foundation Trust, on developing the Affinity monitor

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jun 01,2017

Aidence raises €2.25 million for its AI diagnosis software

Dutch health tech firm Aidence has raised €2.25 million in seed round from henQ, Northzone, and Health Innovations. Aidence develops AI-based imaging software for the healthcare industry for faster diagnosing of x-ray, MRI, and CT images. The company claims its computer-aided diagnostics software makes diagnoses cheaper and more accurate with "human-level accuracy" that will address the shortage of radiologists.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 18,2017

Insilico Medicine Raises $4 million in Equity Financing

Insilico Medicine has raised $4 million USD through a private offering of securities for its artificial intelligence-driven drug discovery and aging research, according to the SEC form registered.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 23,2017

Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS™ Causal Machine Learning and Simulation AI Platforms

GNS Healthcare (GNS), a leading precision medicine company, today announced that it has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company�s REFS� causal machine learning and simulation platform and solutions across drug discovery & development, value-based drug solutions, care management, and health system business optimization. With this investment, Amgen Ventures joins other leading biopharma companies Celgene and Zambon Pharmaceuticals, leading health plans Regence Blue Cross Blue Shield (Cambia Health Solutions), and Horizon Blue Cross of NJ and provider Heritage Provider Network, in addition to Mitsui, GHO Capital, and Fort Rock Capital as shareholders of GNS.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING